GB9625795D0 - Novel treatment - Google Patents

Novel treatment

Info

Publication number
GB9625795D0
GB9625795D0 GBGB9625795.1A GB9625795A GB9625795D0 GB 9625795 D0 GB9625795 D0 GB 9625795D0 GB 9625795 A GB9625795 A GB 9625795A GB 9625795 D0 GB9625795 D0 GB 9625795D0
Authority
GB
United Kingdom
Prior art keywords
novel treatment
novel
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9625795.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9625795.1A priority Critical patent/GB9625795D0/en
Publication of GB9625795D0 publication Critical patent/GB9625795D0/en
Priority to JP52623998A priority patent/JP2001510461A/en
Priority to CA002274858A priority patent/CA2274858A1/en
Priority to EP97953793A priority patent/EP0948325A2/en
Priority to PCT/EP1997/006971 priority patent/WO1998025594A2/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
GBGB9625795.1A 1996-12-12 1996-12-12 Novel treatment Pending GB9625795D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9625795.1A GB9625795D0 (en) 1996-12-12 1996-12-12 Novel treatment
JP52623998A JP2001510461A (en) 1996-12-12 1997-12-09 Lamotrigine in the treatment and prevention of migraine
CA002274858A CA2274858A1 (en) 1996-12-12 1997-12-09 Novel treatment
EP97953793A EP0948325A2 (en) 1996-12-12 1997-12-09 Lamotrigine in the treatment and prophylaxis of migraine
PCT/EP1997/006971 WO1998025594A2 (en) 1996-12-12 1997-12-09 Lamotrigine in the treatment and prophylaxis of migraine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9625795.1A GB9625795D0 (en) 1996-12-12 1996-12-12 Novel treatment

Publications (1)

Publication Number Publication Date
GB9625795D0 true GB9625795D0 (en) 1997-01-29

Family

ID=10804309

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9625795.1A Pending GB9625795D0 (en) 1996-12-12 1996-12-12 Novel treatment

Country Status (5)

Country Link
EP (1) EP0948325A2 (en)
JP (1) JP2001510461A (en)
CA (1) CA2274858A1 (en)
GB (1) GB9625795D0 (en)
WO (1) WO1998025594A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004012741A1 (en) * 2002-07-29 2004-02-12 Glaxo Group Limited Sustained release formulations comprising lamotrigine
EP1438956A1 (en) 2003-01-16 2004-07-21 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful as antimigraine agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9012311D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds
GB9012312D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds
GB9203483D0 (en) * 1992-02-19 1992-04-08 Wellcome Found Anti-inflammatory compounds
US6133299A (en) * 1993-02-25 2000-10-17 Warner-Lambert Company Methods for treating neurodegenerative diseases and disorders using N-(2,6-disubstituted aromatic)-N'-pyridinyl ureas and other anticonvulsant compounds
FR2741879A1 (en) * 1995-12-05 1997-06-06 Esteve Labor Dr FLUOROPHENYL-TRIAZINE AND PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS

Also Published As

Publication number Publication date
CA2274858A1 (en) 1998-06-18
WO1998025594A2 (en) 1998-06-18
WO1998025594A3 (en) 1998-09-17
EP0948325A2 (en) 1999-10-13
JP2001510461A (en) 2001-07-31

Similar Documents

Publication Publication Date Title
GB9411080D0 (en) Treatment
GB9700899D0 (en) Novel treatment
GB9519033D0 (en) Treatment
GB9619492D0 (en) Novel treatment
GB9410512D0 (en) Novel treatment
ZA976593B (en) Novel treatment
GB9411635D0 (en) Novel treatment
GB9608657D0 (en) Novel treatment
GB2355006B (en) Materials treatment
GB9625795D0 (en) Novel treatment
GB9612752D0 (en) Novel treatment
GB9620085D0 (en) Cosmetic treatment
GB9721692D0 (en) Novel treatment
GB9610986D0 (en) Novel treatment
GB9616415D0 (en) Novel treatment
GB9616408D0 (en) Novel treatment
GB9616407D0 (en) Novel treatment
GB9614739D0 (en) Novel treatment
GB9614751D0 (en) Novel treatment
GB9616413D0 (en) Novel treatment
GB9625201D0 (en) Novel treatment
GB9616409D0 (en) Novel treatment
GB9616410D0 (en) Novel treatment
GB9619493D0 (en) Novel treatment
GB9616414D0 (en) Novel treatment